THE EXTRA HEALTH CARE COSTS ASSOCIATED WITHANTIMICROBIAL PROPHYLAXIS IN COLORECTAL SURGICAL PATIENTS- AN EXPLORATION OF PROFILING DATA FROM A UNIVERSITY HOSPITAL IN JAPAN
Author(s)
Hirose M1, Egami K2, Tsuda Y2, Oh EH31Shimane University Hospital, Izumo, Shimane, Japan, 2St. Mary's Hospital, Kurume, Fukuoka, Japan, 3Hyupsung University, Hwaseong-Si, Gyeonggi-Do, South Korea
Presentation Documents
OBJECTIVES: Postoperative infections bring about an expansion of length of hospital stay (LOS) and extra medical costs. METHODS: We analyze the relationship between variations in antimicrobial prophylaxis (AMP) and extra medical costs in surgical patients with colorectal malignancies. Utilizing profiling administrative data, we analyzed 161 admitted patients between 2007 and 2009 to a university hospital. We classified the patients into two classes based on AMP duration: the control group (112) and the case group (49). Most patients from both groups were appropriately given AMP agents consistent with the guidelines of infection-related associations. RESULTS: The LOS of the control group (24.6 ± 12.1 days) was shorter than that of the case (49.4 ± 35.2) (p<0.05). Hospitalization charge of the control group (15130 ± 3930 USD) was lower than that of the case (23130 ± 1212) (p<0.05), but hospitalization charge per day of the control group (670 ± 160 USD) was higher than that of the case (530 ± 130) (p<0.05). Furthermore, 73 cases of the control group were given on the day of surgery till the first postoperative day, and 39 cases were given to the second and third postoperative days. LOS of the former (22.7 ± 9.5 days) was shorter than that of the latter (28.3 ± 15.5) (p<0.05). CONCLUSIONS: AMP agents in our hospital were found to generally given according to the recommended guidelines. It is important for the hospital administrators to quantify the additional costs on top of the primary diagnosis in order to properly deal with infection control and hospital management.
Conference/Value in Health Info
2011-11, ISPOR Europe 2011, Madrid, Spain
Value in Health, Vol. 14, No. 7 (November 2011)
Code
PGI22
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Gastrointestinal Disorders